Urology Devices Market Hitting USD 67.7 Billion by 2033

Introduction

The Global Urology Devices Market is poised for significant growth, projected to increase from USD 38.5 billion in 2023 to USD 67.7 billion by 2033, advancing at a CAGR of 5.8% during the forecast period. This expansion is propelled by key factors including aging demographics, technological advancements, and a heightened focus on enhancing patients’ quality of life. As the global population ages, there is a rise in urological conditions such as benign prostatic hyperplasia (BPH) and urinary incontinence, necessitating effective urology devices. Moreover, advancements in minimally invasive surgeries and robotic technologies are transforming treatments, offering less invasive options and quicker recovery times.

Research and development (R&D) in the sector are driving innovations in urology devices. Institutions like Johns Hopkins and Mayo Clinic are at the forefront, conducting extensive clinical trials that refine treatments and improve outcomes. The integration of these innovations ensures that the next generation of urology devices is more efficient and patient-centric. Furthermore, there is a trend toward multidisciplinary care models, enhancing the management of complex urological conditions through comprehensive and specialized care approaches.

In recent developments, Teleflex Inc. acquired Palette Life Sciences in July 2023 for approximately $650 million, integrating Barrigel®, a rectal spacer that improves radiation treatment precision for prostate cancer. This acquisition is expected to contribute significantly to Teleflex’s revenue growth. In another strategic move, Stryker acquired Artelon, Inc. in July 2024, specializing in soft tissue fixation to broaden its sports medicine portfolio, enhancing surgical options in foot, ankle, and sports medicine.

Further illustrating industry progress, Olympus received FDA clearance in April 2024 for its RenaFlex single-use ureteroscope system, designed to enhance urinary tract diagnostic and therapeutic procedures. The system improves access and visualization crucial for treating conditions like kidney stones. Subsequently, Olympus launched a new 4K camera head in September 2024, enhancing the resolution and accuracy of endoscopic urology procedures.

Additionally, Terumo Corporation established a venture capital fund named “Terumo Ventures” in August 2024, allocating $75 million to invest in early-stage companies focusing on cardiovascular and chronic disease management, and digital technologies. This fund is part of Terumo’s strategy to transition from medical devices to comprehensive healthcare solutions, promoting innovation and strategic investments in the healthcare sector. This proactive approach in funding and acquisitions underscores the industry’s shift towards comprehensive, patient-oriented healthcare innovations.

Key Takeaways

• The Urology Devices Market is projected to grow from USD 38.5 billion in 2023 to USD 67.7 billion by 2033.
• This market is expected to expand at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2033.
• Accessories dominate the product category, holding a 42.4% share of the global urology devices market.
• Kidney diseases represent the largest application segment, accounting for 39.5% of the market.
• Hospitals and ambulatory surgical centers are the primary end users, comprising 59.8% of the market in 2023.
• In 2023, North America held the largest geographical market share at 33.7%, amounting to USD 12.9 billion in revenue.
• The market’s growth is fueled by rising instances of kidney failures and chronic diseases, boosting demand for urology devices.

Urology Devices Statistics

Urology Health Statistics in the UK

• Annually, approximately 10,000 individuals are diagnosed with urological cancer, ranking it as the 11th most common type of cancer in the UK.
• Between 3 and 6 million people, or about 5% of men and 13% of women, experience urinary incontinence in the UK.
• Interstitial cystitis affects around 400,000 UK residents, with women comprising 90% of these cases.
• Over 70% of individuals with urinary incontinence report significant distress, irrespective of race or ethnicity.
• Lifetime risk of a urinary tract infection (UTI) is 1 in 2000 for men and 50% to 60% for women.
• One in six women in the UK report symptoms of overactive bladder (OAB).
• The prevalence of underactive bladder (UAB) in men under 50 ranges from 9% to 23%, increasing to nearly 50% in men over 70.
• In older women, UAB affects 12% to 45%.

Screening Guidelines for Urological Health

• Men aged 40 with more than one close relative diagnosed early with prostate cancer should consider screening.
• African American men and those with a family history of prostate cancer by age 65 should start screening at 45.
• Men aged 50 and above with average risk and a life expectancy of at least 10 more years are advised to undergo screening.
• It is important for clinicians to discuss the potential severe side effects of treatments and the possibility of minimal impact on slow-growing cancers.

Global Urology Healthcare Needs

• A predicted 46% shortage of urologists by 2035 is expected to challenge the US healthcare system due to an aging population.
• Annually, over 1 million urological surgeries are performed in the United States.
• Globally, approximately 2.3 million individuals utilize urology devices for various conditions.
• The United States hosts around 130 accredited urology residency programs.
• In 2023, urology research received approximately $280 million in funding from the National Institutes of Health.

Growth Projections Across Key Healthcare Sectors

• Urinary Drainage Systems: Expected to reach around USD 4.9 billion by 2032, up from USD 2.7 billion in 2022, with an annual growth rate of 4.3% from 2023 to 2032.
• Urinalysis Sector: Predicted to grow to USD 9.2 billion by 2033 from USD 4.3 billion in 2023, achieving a growth rate of 7.9% from 2024 to 2033.
• Neurology Sector: Forecasted to expand to USD 6.8 billion by 2033 from USD 3.3 billion in 2023, at a 7.5% annual growth rate from 2024 to 2033.
• AI in Neurology Operating Rooms: Valued at USD 1,066.0 million in 2023, anticipated to surge to USD 61.1 million by 2033, with a robust growth rate of 33.1% from 2024 to 2033.
• Nephrology Therapeutics: Projected to grow to USD 27.8 billion by 2033 from USD 15.8 billion in 2023, at a growth rate of 5.8% from 2024 to 2033.
• Gynecological Devices: Expected to advance to USD 21.7 billion by 2033 from USD 9.7 billion in 2023, with an annual growth rate of 8.4% from 2024 to 2033.
• Interventional Cardiology Devices: Predicted to rise to USD 38 billion by 2032 from USD 18 billion in 2022, growing at an 8.0% annual rate from 2023 to 2032.
• Interventional Cardiology and Peripheral Vascular Devices: Anticipated to reach around USD 34 billion by 2033, up from USD 17 billion in 2023, growing at a 7.2% annual rate from 2024 to 2033.
• AI in Cardiology: Valued at USD 1.5 billion in 2023, projected to increase significantly to USD 40.5 billion by 2033, with a CAGR of 39.4%.
• Oncology Therapeutics: Expected to grow to USD 548.7 billion by 2033 from USD 201.5 billion in 2023, with a growth rate of 10.5% from 2024 to 2033.
• Oncology Sector: Projected to expand to USD 628 billion by 2032 from USD 208 billion in 2022, at a growth rate of 12% from 2022 to 2032.
• Radiation Oncology: Expected to reach around USD 19.2 billion by 2032, up from USD 8.9 billion in 2023, growing at a 9.1% annual rate from 2023 to 2032.
• Pulmonary Drug Delivery Systems: Forecasted to grow to USD 97.8 billion by 2033 from USD 56.2 billion in 2023, with a growth rate of 5.7% from 2024 to 2033.

Emerging Trends

• Artificial Intelligence Integration: Artificial intelligence (AI) is revolutionizing the field of urology by optimizing patient management protocols. For instance, devices like UroFlo are incorporating AI to automate bladder irrigation processes. This integration not only enhances the efficiency of treatments but also helps in cutting healthcare costs significantly. By providing more accurate and timely interventions, AI-enabled devices are improving outcomes for patients with conditions such as hematuria.
• Advanced Laser Treatments: The adoption of new laser technologies, such as the GreenLight Laser system, marks a significant advancement in the treatment of benign prostatic hyperplasia (BPH). These laser treatments are less invasive than traditional surgical approaches, offering benefits like quicker recovery times and fewer post-operative complications. The precision and minimal invasiveness of these treatments make them a preferred choice for both patients and healthcare providers.
• Telemedicine and Remote Monitoring: With the increasing demand for continual, accessible care, telemedicine and remote monitoring are gaining momentum in the field of urology. These technologies enable real-time monitoring and management of patients remotely, reducing the need for frequent in-office visits. This trend is particularly beneficial for ongoing patient management, making healthcare more accessible and efficient.
• Precision Medicine: Personalized medicine is becoming more prevalent in urology, especially in the area of urologic oncology. Leveraging genetic data, urologists are able to design tailored treatment plans that significantly enhance the efficacy of interventions. This approach not only improves patient outcomes but also minimizes the risks associated with one-size-fits-all treatment methods.
• Robotic Surgery Advancements: Robotic surgery is another area witnessing rapid growth within urology. These systems enhance surgical precision, particularly in complex procedures like prostatectomies, and have been linked to shorter recovery times and reduced complications. The proliferation of robotic surgery is expected to continue as more healthcare facilities adopt this cutting-edge technology.

Use Cases

• Kidney Stone Management: Urology devices, specifically ureteroscopes, play a crucial role in the management of kidney stones. These devices utilize cutting-edge instruments and laser technologies, such as the holmium laser, to efficiently break down kidney stones. This minimally invasive approach is highly effective and favored for its ability to ensure rapid recovery for patients. The precision of these tools minimizes discomfort and speeds up the healing process, making it a preferred choice in kidney stone treatment.
• Prostate Health: For treating Benign Prostatic Hyperplasia (BPH), the GreenLight Laser is a commonly used device. This innovative laser technology efficiently vaporizes excessive prostate tissue, alleviating symptoms without the complications associated with traditional, more invasive surgeries. The use of this laser ensures a safer procedure, reducing risks and promoting a quicker postoperative recovery.
• Cancer Treatment: In the realm of urologic oncology, devices and methods such as laparoscopy and laser therapies are instrumental in treating urinary tract cancers. These techniques are designed to be minimally harmful while targeting the disease effectively. By focusing treatment specifically on affected areas, they help preserve more of the patient’s urinary function and overall health, offering a significant advantage over more invasive alternatives.
• Incontinence Treatment: The field of urology has seen significant advancements in the treatment of urinary incontinence through the use of sophisticated devices. Technologies such as artificial urinary sphincters and advanced implants are revolutionizing patient care. These devices help manage bladder function more effectively, significantly enhancing the quality of life for individuals suffering from incontinence.
• Diagnostic Enhancements: Urology benefits greatly from advancements in diagnostic imaging and biomarker analysis. These technologies enable the earlier and more accurate diagnosis of conditions like prostate cancer. Early detection is crucial as it allows for timely intervention, potentially reducing the severity of the illness and enhancing treatment outcomes. This progress in diagnostics represents a pivotal development in the early identification and management of urological diseases.

Conclusion

The Urology Devices Market is advancing rapidly, driven by aging populations, technological innovation, and rising demand for improved patient care. As urological conditions like BPH, urinary incontinence, and kidney diseases grow, so does the need for effective, minimally invasive treatments. Key players are leveraging robotic surgery, laser treatments, and artificial intelligence to enhance diagnostic precision and treatment outcomes. Investments and acquisitions signal a shift towards holistic, patient-centered solutions, with companies aiming to integrate personalized and accessible care. These developments are setting the stage for a robust and resilient urology devices market, focused on quality, efficiency, and improved patient experiences.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF